Griffin Asset Management Inc. reduced its stake in Nano-X Imaging Ltd. (NASDAQ:NNOX - Free Report) by 36.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 117,074 shares of the company's stock after selling 66,005 shares during the period. Griffin Asset Management Inc. owned 0.20% of Nano-X Imaging worth $605,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of NNOX. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Nano-X Imaging by 232.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,160,806 shares of the company's stock valued at $10,793,000 after purchasing an additional 1,510,806 shares during the last quarter. Nuveen LLC acquired a new position in shares of Nano-X Imaging in the first quarter valued at $657,000. AQR Capital Management LLC acquired a new position in shares of Nano-X Imaging in the first quarter valued at $178,000. Virtu Financial LLC acquired a new position in shares of Nano-X Imaging in the first quarter valued at $139,000. Finally, Gainplan LLC acquired a new position in shares of Nano-X Imaging in the second quarter valued at $59,000. 21.49% of the stock is currently owned by institutional investors and hedge funds.
Nano-X Imaging Stock Down 4.9%
NNOX opened at $3.90 on Monday. Nano-X Imaging Ltd. has a twelve month low of $3.60 and a twelve month high of $11.00. The company has a 50-day simple moving average of $4.06 and a 200 day simple moving average of $4.73. The stock has a market capitalization of $225.34 million, a price-to-earnings ratio of -4.33 and a beta of 1.89.
Nano-X Imaging (NASDAQ:NNOX - Get Free Report) last posted its quarterly earnings data on Tuesday, August 12th. The company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of ($0.15) by ($0.08). Nano-X Imaging had a negative return on equity of 32.09% and a negative net margin of 468.29%.The firm had revenue of $3.04 million for the quarter, compared to the consensus estimate of $3.20 million. Sell-side analysts anticipate that Nano-X Imaging Ltd. will post -0.92 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several research firms recently commented on NNOX. Weiss Ratings restated a "sell (d-)" rating on shares of Nano-X Imaging in a research note on Wednesday, October 8th. D. Boral Capital restated a "buy" rating and issued a $8.00 price target on shares of Nano-X Imaging in a research note on Friday, September 19th. LADENBURG THALM/SH SH upgraded shares of Nano-X Imaging to a "strong-buy" rating in a research note on Monday, July 14th. Finally, Alliance Global Partners upgraded shares of Nano-X Imaging to a "strong-buy" rating in a research note on Monday, August 11th. Two research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $8.50.
View Our Latest Report on Nano-X Imaging
Nano-X Imaging Profile
(
Free Report)
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nano-X Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nano-X Imaging wasn't on the list.
While Nano-X Imaging currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.